期刊名称:COST EFFECTIVENESS AND RESOURCE ALLOCATION
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
Cost Effectiveness and Resource Allocation considers manuscripts on all aspects of cost-effectiveness analysis, including conceptual or methodological work, economic evaluations, and policy analysis related to resource allocation at a national or international level.
Cost Effectiveness and Resource Allocation is aimed at health economists, health services researchers, and policy-makers with an interest in enhancing the flow and transfer of knowledge relating to efficiency in the health sector. Manuscripts are encouraged from researchers based in low- and middle-income countries, with a view to increasing the international economic evidence base for health. The journal particularly solicits manuscripts on the costs, effectiveness, or cost-effectiveness of health interventions, based on primary empirical research/data collection or via a modelling approach. A health intervention is defined broadly as any action whose primary intent is to improve health - promotive, preventive, curative and rehabilitative actions at the clinical or population level. As well as manuscripts reporting cost or cost-effectiveness data, the journal also considers contributions that report or discuss methodological aspects of economic evaluation - such as disease modelling, cost estimation, or uncertainty - and policy-related issues such as the interplay between efficiency and other decision-making criteria.
There will never be sufficient resources available to allow all possible means of improving health to be provided to all people who might benefit from them. Information on the health improvements resulting from possible uses of scarce resources is critical to informed decision making about where scarce resources should be allocated. Nowhere is this truer than in low- and middle-income countries, where there is greatest pressure on limited resources for health and health care. Cost Effectiveness and Resource Allocation aims to be a home for this type of information.
Open access
All articles published by Cost Effectiveness and Resource Allocation are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Cost Effectiveness and Resource Allocation you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Article-processing charges
Open access publishing is not without costs. Cost Effectiveness and Resource Allocation therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
Indexing services
All articles published in Cost Effectiveness and Resource Allocation are included in:
- CABI
- Cinahl
- Citebase
- DOAJ
- Embase
- Global Health
- OAIster
- PubMed
- PubMed Central
- SCImago
- Scopus
- SOCOLAR
- Zetoc
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including Web of Science (Thomson Reuters) to ensure that articles published in Cost Effectiveness and Resource Allocation will be available in their databases when appropriate.
Peer-review policy
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Cost Effectiveness and Resource Allocation operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
Submitted manuscripts will be reviewed by two or three external experts. When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data or to identify areas where more data are needed. Cost Effectiveness and Resource Allocation normally allows authors a maximum of two revisions of a manuscript. Peer reviewers are asked to say if the manuscript is not sufficiently clearly written for publication. In such cases authors are asked to revise the manuscript, seeking, if necessary, the assistance of colleagues or a commercial editing service. Edited by Joan Rovira, Cost Effectiveness and Resource Allocation is supported by an expert Editorial Board.
Cost Effectiveness and Resource Allocation considers manuscripts spanning a wide range of scientific interests, as long as the results and conclusions are scientifically justified and not misleading.
Instructions to Authors
Submission guidelines
Our 3-step submission process
-
Before you submit
Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.
-
Ready to submit
To give your manuscript the best chance of publication, follow these policies and formatting guidelines.
-
Submit and promote
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Submit your manuscript in Editorial Manager
Editorial Board
Editor-in-Chief Joan Rovira, University of Barcelona, Spain
Deputy Editor-in-Chief Sitaporn Youngkong, Mahidol University, Thailand
Deputy Editors Rob Baltussen, Radboud University Medical Center, Netherlands Damian Walker, Bill & Melinda Gates Foundation, USA
Associate Editors Angela Acosta, Univerisdad de los Andes, Colombia Marcos Bosi, Ferraz Federal University of São Paulo, Brazil Nathorn Chaiyakunapruk, Monash University, Malaysia Álvaro Hidalgo-Vega, University of Castilla-La Mancha, Spain Arindam Nandi, Center for Disease Dynamics, Economics & Policy, USA Reiner Leidl, Ludwig Maximilians-University, Germany Hector Ochoa, ECOSUR, Mexico Cesar Sanabria, Universidad San Marcos, Peru Sabine Vogler, Gesundheit Österreich GmbH (Austrian Public Health Institute), Austria John Yfantopoulos, University of Athens, Greece
Editorial Board Arnab Acharya, London School of Hygiene and Tropical Medicine, UK Kathryn Antioch, Monash University, Australia Stefano Bertozzi, INSP and Bill & Melinda Gates Foundation, Mexico Dan Brock, Harvard School of Public Health, USA Werner Brouwer, Erasmus University, Netherlands Francois R Chapuis, Hospices Civils de Lyon, France Dan Chisholm, WHO, Switzerland Michael Drummond, University of York, UK Tim Ensor, Oxford Policy Management, UK Julia Fox-Rushby, Brunel University, UK Kevin D Frick, Johns Hopkins Carey Business School, USA Marthe Gold, City University of New York Medical School, USA Pirom Kamol-Ratanakul, Chulalongkorn University, Thailand Joses Kirigia, WHO, Congo Deborah McFarland, Emory University, USA Raúl Molina, Universidad Autonoma Metropolitana-Iztapalapa, Mexico Louis W Niessen, Johns Hopkins University School of Public Health, Netherlands Jeff Richardson, Monash University, Australia Frans Rutten Erasmus University, Netherlands Kevin A Schulman, Duke Clinical Research Institute, USA Tessa Tan-Torres Edejer, WHO, Switzerland Miguel Uribe, Universidad Javeriana, Colombia Daniel Wikler, Harvard School of Public Health, USA
|